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with arterial stiffness in patients with
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Background: Patients with peritoneal dialysis are in the persistent inflammation state and have elevated arterial
stiffness. Neutrophil-lymphocyte ratio(NLR) is a new inflammatory marker in renal and cardiac disorders. Brachial-ankle
pulse wave velocity (baPWV) is a non-invasive measurement, which is widely used as a surrogate marker of arterial
stiffness. However, there is little evidence to show an association between NLR and baPWV in patients with peritoneal
dialysis. The aim of this cross-section study was to investigate the relationship between NLR and arterial stiffness
measured by baPWV in patients with peritoneal dialysis.
Methods: In this cross-section study, 101 patients with peritoneal dialysis were enrolled from January 2014 to June
2015. According to average baPWV level (1847.54 cm/s), the patients were categorized into two groups, low group and
high group. baPWV, which reflects arterial stiffness, was calculated using the single-point method. Clinical data were
collected in details. NLR was calculated using complete blood count. Associations between NLR and baPWV were
assessed using Pearson’s correlation and linear regression analysis.
Results: The NLR was significantly lower in the low baPWV group than in the high baPWV group (p= 0.03). There were
positive correlations between baPWV and neutrophil count (r = 0.24, p = 0.01) and NRL(r = 0.43, P < 0.01), and there was a
negative correlation between baPWV and lymphocyte count (r = -0.23, p = 0.01). In addition, albumin, phosphorous and
intact parathyroid hormone showed negative correlations with baPWV (r = −0.32, p < 0.01; r = −0.28, p < 0.01; r = −0.25,
p = 0.01, respectively). Age and hsCRP showed positive correlations with baPWV (r = 0.47, p < 0.01; r = 0.25, p = 0.01). In
multivariate analysis, NLR independently correlated with baPWV in patients with peritoneal dialysis (β = 0.33, p < 0.01),
even after adjustment for various confounders.
Conclusion: Our study suggests that NLR was an independently associated with arterial stiffness in patients with
peritoneal dialysis. However, further prospective studies are needed to confirm cause-and-effect relationship between NLR
and baPWV, and to investigate whether anti-inflammatory treatment could improve arterial stiffness in patients with
peritoneal dialysis.
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In 2014, 55,373 patients received peritoneal dialysis (PD)
in China. Cardiovascular disease is the first etiology of
mortality and morbidity, accounting for nearly 60% of all
deaths in the patients with PD [1]. Microinflammation is a
key component of the malnutrition- inflammation-
atherosclerosis and calcification syndrome (MIAC syn-
drome), which is associated with increased risk of cardio-
vascular disease in patients with PD.
Recently, neutrophil-to-lymphocyte ratio (NLR),
calculated as a ratio of neutrophil to lymphocyte in
peripheral blood, is regarded a readily available indi-
cator for the severity and extension of systemic in-
flammation and atherosclerosis in renal and cardiac
disorders [2, 3].
Elevated arterial stiffness is an early marker of sys-
temic atherosclerosis, which has been shown to be a
powerful independent predictor of cardiovascular events
and all-cause mortality in chronic kidney disease(CKD)
[4]. Pulse wave velocity (PWV) is a non-invasive meas-
urement, which is widely used as a surrogate marker of
arterial stiffness [5]. Brachial-ankle PWV (baPWV)
correlates with the gold standard measurement, carotid-
femoral PWV [6]. Increasing studies demonstrated that
elevated baPWV is associated with increased risk of
renal disease and cardiovascular diseases, as well as
increased total mortality [7, 8].
However, there is little evidence to show an association
between NLR and baPWV in patients with PD. There-
fore, we aimed to evaluate the relationship between NLR
and baPWV in patients with PD.Fig 1. Patient selection schemeMethods
Patients
Patients with over one-month PD were included in this
cross-section study from January 2014 to June 2015 in
Ningbo No.2 Hospital. The number of cases during the
study period determined the sample size. It has adhered to
the STROBE guidelines for observational studies. Accord-
ing to average baPWV level (1847.54 cm/s), the patients
were categorized into two groups, low baPWV and high
baPWV. Patients with active infection, severe liver dysfunc-
tion, malignancy, hematological diseases were excluded.
The flow diagram is shown in Fig. 1. Patients were dialyzed
with dextrose peritoneal dialysate produced by Baxter
Healthcare (Guangzhou, China). This study was approved
by the Ethics Committee of Ningbo No.2 Hospital.
Demographic data and biochemical measurements
The demographic data included age, gender, etiology of
end-stage renal disease, prevalence of diabetes, the dialysis
duration, current smoking status, and atherosclerotic vas-
cular disease (AVD) history. Physical examination in-
cluded blood pressure, height, and weight. Blood sample
was drawn in the morning following a fasting period of
over 8 h. 24-hours ultrafiltration volume, and urine output
volume were recorded. Biochemical measurements, using
standard laboratory techniques in the same laboratory
center, included blood cell counts, neutrophic counts,
lymphocyte counts, haemoglobin, platelets, calcium, phos-
phorus, intact parathyroid hormone (iPTH), creatinine,
urea nitrogen, total cholesterol, triglycerides, albumin and
highly sensitive C-reactive protein (hsCRP). Complete
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mex Corporation). Serum calcium, phosphate, renal pro-
files, albumin hsCRP, and lipid profiles were measured




Age (year) 48.60 ± 14.20
Gender (male, %) 30(51.72)
Body mass index (kg/m2) 21.16 ± 3.03





Chronic glomerular nephritis (%) 44(75.86)
Diabetic kidney disease (%) 5(5.17)
Others(%) 9(15.51)
current smoking status(%) 5(8.62)
cardiovascular disease history(%) 3(5.17)







Hemoglobin (g/L) 104.17 ± 24.25
Albumin (g/L) 36.18 ± 4.84
Total cholesterol (mmol/L) 5.18 ± 1.21
Triglycerides (mmol/L) 1.78 ± 0.95
Calcium (mmol/L) 2.10 ± 0.24
Phosphorus (mmol/L) 1.60 ± 0.37
Intact parathyroid hormone (pg/ml) 434.62 ± 328.77
rGFR (ml/min/1.73 m2) 5.67 ± 2.68




WBC (*10^3/mm3) 6.47 ± 1.71
Neutrophil (*10^3/mm3) 4.32 ± 1.35
Lymphocyte(*10^3/mm3) 1.45 ± 0.43
NLR 3.17 ± 1.20
baPWV(cm/s) 1506.21 ± 188.69
MAP mean arterial pressure, UF ultrafiltation, GFR glomerular filtration rate, hsCRP h
pulse wave velocity, NLR neutrophil-lymphocyte ratio;*p < 0.05Diagnostics). PTH levels were determined using ADVIA
Centaur XP (Siemens Healthcare Diagnostics). All of these
data were collected from Hospital Information System of




63.60 ± 12.65 −5.49 <0.01*
30(69.76) 3.33 0.06


















97.12 ± 18.20 1.66 0.10
31.09 ± 5.70 4.83 <0.01*
4.64 ± 1.26 2.18 0.03*
1.59 ± 1.02 0.96 0.33
2.01 ± 0.23 1.80 0.07
1.37 ± 0.49 2.64 0.01*
298.26 ± 240.22 2.30 0.02*
6.29 ± 2.96 −1.09 0.27




6.42 ± 2.11 0.13 0.89
4.41 ± 1.71 −0.30 0.76
1.24 ± 0.42 2.45 0.01*
3.89 ± 1.92 −2.15 0.03*
2284.45 ± 508.79 −9.55 <0.01*
igh-sensitive C-reactive protein, WBC white blood count, baPWV brachial-ankle
Table 2 Correlation analysis for variables and baPWV
Variables r p-value
Age (years) 0.47 <0.01*
Body mass index (kg/m2) −0.11 0.25
Peritoneal dialysis duration (months) −0.01 0.84
Diabetes 0.25 0.01*
current smoking status 0.23 0.01*
atherosclerotic vascular disease history 0.24 0.01*
MAP (mmHg) 0.17 0.08
Net UF (ml/day) 0.15 0.13
Urine output (ml/day) 0.15 0.11
Hemoglobin (g/L) −0.15 0.12
Albumin (g/L) −0.32 <0.01*
Total cholesterol (mmol/L) −0.12 0.22
Triglycerides (mmol/L) −0.09 0.34
Calcium (mmol/L) −0.03 0.70
Phosphorus (mmol/L) −0.28 <0.01*
Intact parathyroid hormone (pg/ml) −0.25 0.01*
rGFR (ml/min/1.73 m2) 0.14 0.13
Kt/V −0.15 0.12
hsCRP(mg/dl) 0.25 0.01*
WBC (*10^3/mm3) 0.16 0.09
Neutrophil (*10^3/mm3) 0.24 0.01*
Lymphocyte(*10^3/mm3) −0.23 0.01*
NLR 0.43 <0.01*
MAP mean arterial pressure, UF ultrafiltation, GFR glomerular filtration rate,
hsCRP high-sensitive C-reactive protein, WBC white blood count, baPWV
brachial-ankle pulse wave velocity, NLR neutrophil-lymphocyte ratio;*p < 0.05
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lymphocyte in peripheral blood. Mean arterial pressure
(MAP) was calculated as 1/3 systolic blood pressure plus
2/3 diastolic blood pressure. Body mass index (BMI) was
calculated as weight (kg) divided by the square of height
(m2). Residual renal function (RRF) was assessed by cal-
culating the glomerular filtration rate (GFR) using the
Chronic Kidney Disease Epidemiology Collaboration
equation. Adequacy of dialysis (total Kt/V) was mea-
sured using PD Adequest software.
Measurement of the brachial-ankle pulse wave velocity
(baPWV)
baPWV was measured according to the method in a pre-
vious study [9], measurement of baPWV was performed
after a 15-min rest in a supine position in a quiet and
temperature-controlled room. The baPWV was mea-
sured based on regular methods using an Omron wave-
form analyzer (BP-203RPE III; Omron Co. Ltd, Dalian,
China). The pulse wave velocity between the bilateral
brachial and ankle artery was measured by placing both
the arm and ankle in cuffs into which an oscillometric
sensor was implanted. All the measurement were com-
pleted by the same doctor.
Statistical analysis
All statistical analyses were performed with SPSS soft-
ware, version 19.0 (SPSS Inc.USA). A p-value < 0.05 was
considered statistically significant. The results were
expressed as frequencies and percentages for categorical
variables, means with standard deviation for normally
distributed continuous variables, and median values
(interquartile ranges) for non-normally distributed con-
tinuous variables, respectively. Student’s t-test for inde-
pendent samples was used for normally distributed c
ontinuous variables. Comparisons of non-normally dis-
tributed continuous variables were performed using the
Mann-Whitney U-test. For categorical variables, the chi-
square test was used. Correlations of baPWV with NRL
and other variables were assessed using Pearson’s or
Spearman’s correlation analysis. Univariate and multiple
linear regression analyses were performed to identify the
predictors of baPWV. Variables found to be statistically
significant in univariate analyses were entered into
multivariate lineal regression model.
Results
The demographic and biochemical characteristics of 101
subjects, according to baPWV levels are shown in
Table 1. There were 58 patients in the low baPWV group
and 43 patients in the high group. The raw data of the
study can be seen in more detail (see Additional file 1).
There were 100 patients treated with CAPD modality
and one patient treated with APD modality. The primaryetiology of end stage renal disease (ESRD) was chronic
glomerulonephritis in both groups. There were signifi-
cantly more patients with diabetes mellitus in the high
baPWV group compared to the low baPWV group (x2 =
11.63, p < 0.01).The number of the patients with cardio-
vascular diseases and current smoking status were simi-
lar between both groups. There were no differences
between the groups in term of the following parameters:
BMI, peritoneal dialysis duration, ultrafiltration, urine
output, hemoglobin and triglyceride. Levels of albumin,
total cholesterol, phosphorous, iPTH in the low group
were significantly lower than those in the high group
(p < 0.01, p = 0.03, p = 0.01, p = 0.02, respectively).
However, age and hsCRP were significantly higher in the
low group than that in the high group (both p < 0.01).
There were slight differences in MAP, calcium, and Kt/V
between groups, without reaching statistical significance
(p = 0.10, p = 0.07, p = 0.09, respectively). In sub-analysis,
average of baPWV was higher in patients with AVD his-
tory than those without AVD history (t = -2.99, p < 0.01)
When hematologic parameters were analyzed, it was
observed that white blood cell (WBC) count and
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p = 0.76, respectively). However, the lymphocyte count
was significantly higher in low group compared to in
high group (p = 0.01). NLR was significantly lower in the
low group than that in the high group (p = 0.03)
(Table 1).
Correlations between baPWV and parameters in patients
with PD are shown in Table 2. According to the results,
there were positive correlations of baPWV and neutrophil
count (r = 0.24, p = 0.01) and NRL (r = 0.43, p < 0.01), and
there was a negative correlation between baPWV and
lymphocyte count (r= -0.23, P = 0.01). In addition, albumin,
phosphorous and iPTH showed negative correlations with
baPWV (r= -0.32, P < 0.01; r = -0.28, P < 0.01; r = -0.25, P =
0.01). Age and hsCRP showed positive correlation with
baPWV (r = 0.47, p < 0.01; r = 0.25, p = 0.01). Correlation
between baPWV and MAP approached statistical signifi-
cance (r = 0.17, p = 0.08).
Variables found to be statistically significant in uni-
variate analyses were entered into multivariate lineal
regression model, age, diabetes, current smoking
status, AVD history, albumin,phosphorus, iPTH and
NLR. In multivariate analysis, NLR independently
correlated with baPWV in patients with PD (β = 0.33,
p < 0.01) (Table 3).
Discussion
This study revealed that NLR was higher in the low
baPWV group than that in the high baPWV group.
Moreover, it showed that NRL, a new inflammatory




Age (year) 0.47 5.3
Body mass index (kg/m2) −0.11 −1
Diabetes (%) 0.23 2.4
current smoking status (%) 0.25 2.5
atherosclerotic vascular disease history (%) 0.28 2.9
MAP (mmHg) −0.17 1.7
Albumin (g/L) −0.31 −3
Calcium (mmol/L) −0.03 −0
Phosphorus (mmol/L) −0.28 −2
iPTH (pg/ml) −0.25 −2




MAP mean arterial pressure, UF ultrafiltation, GFR glomerular filtration rate, hsCRP h
pulse wave velocity, NLR neutrophil-lymphocyte ratio;*p < 0.05patients with PD. Multiple linear regression analysis
showed that NLR was an independent factor for
increased baPWV.
Compared to general population, CKD patients have
increased arterial stiffness [10]. Arterial stiffness plays a
key role in the pathophysiology of the cardiovascular
disease. baPWV is a commonly applied non-invasive
technique to measure arterial stiffness [11]. Accumulated
evidence has indicated that baPWV is an independent
predictor of cardiovascular outcomes in patients with
CKD [12, 13]. In our study the average level of baPWV
was higher in patients with AVD history than those
without AVD history. Recent studies have emphasized
the importance of inflammation in the pathogenesis of
arterial stiffness. Duprez et al. have demonstrated a sig-
nificant correlation between arterial stiffness and hsCRP
[14]. Also, previous studies suggested that reduction in
inflammation can decrease arterial stiffness [15].
Recent studies have shown that a potential association
between NLR and baPWV in patients with type 1 dia-
betes [16], osteoporosis [17] or psoriasis [18]. Our study
was also in accordance with these studies. The study is
the first to show that serum NLR was positively and in-
dependently correlated with baPWV in adult PD pa-
tients, even after adjustment for various confounders.
Moreover, NLR was superior to hsCRP in association
with PWV. These results demonstrated that inflamma-
tion plays a crucial role in the development of arterial
stiffness among patients with PD [19].
The NLR reflects both neutrophil and lymphocyte
counts. Our results showed that neutrophil counts werewith peritoneal dialysis
Multivariate
P-value β coefficient t P-value
8 <0.01* 0.25 2.61 <0.01*
.14 0.26 – – –
4 0.01* 0.04 0.53 0.59
5 0.01* −0.18 −1.00 0.31
9 <0.01* 0.32 1.75 0.08
2 0.08 – – –
.34 <0.01* −0.17 −1.99 0.04*
.37 0.70 – – –
.98 <0.01* −0.12 −0.14 0.16
.62 0.01* −0.43 −0.49 0.66
9 0.13 – – –
.57 0.12 – – –
6 0.05 – – –
4 <0.01* 0.33 3.91 <0.01*
igh-sensitive C-reactive protein, WBC white blood count, baPWV brachial-ankle
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lymphocyte counts showed significant decrease and NLR
showed significant increase in the high group compared to
the low baPWV. Thus, increased NLR are more likely due
to decreased absolute lymphocyte counts rather than in-
creased neutrophil counts in our study. This is consistent
with the study by Solak et al. [20]. The previous study has
shown that NLR is superior to these two leukocyte parame-
ters, the most powerful simple leukocyte count indicators
[21]. Compared to these two count indicators, it is more
stable and less affected by acute conditions which change
one of the individual cell counts.
Patients with PD were in a low graded chronic inflam-
mation state. WBC subtypes play the role in different ways
to promote atherosclerosis. Increasing evidence has shown
that neutrophil directly acts as a mediator of tissue de-
struction to the arterial wall in inflammation conditions
[22]. Lymphopenia may be caused by lymphocyte apop-
tosis in atherosclerotic lesions, which gradually increases
with atherosclerotic burden [23]. Moreover, several studies
showed a relationship between low lymphocyte count and
malnutrition [24, 25]. Thus, the combination of elevated
neutrophils (nonspecific inflammation) and decreased
levels of lymphocytes (regulatory component) into a single
composite marker may provide additional information to
interpret the pathogenesis of arterial stiffness [26]. How-
ever, there is an ongoing debate whether NLR is merely a
surrogate marker of understanding inflammation, or
whether it confers an increased risk per se [20]. More re-
searches are warranted to investigate further.
There are three main limitations in this study. Firstly,
our study population is just from a single center, which
cannot represent the general population. Secondly, due
to the nature of this cross-section study design, we can-
not draw a cause-and-effect relationship. Thirdly, as
there is no healthy control, it is hard to gain the com-
parison of baPWV and NLR between patients with PD
and healthy persons.
Conclusion
In conclusion, our results showed that NLR was inde-
pendently associated with arterial stiffness. It is stable
and ready to evaluate NLR and baPWV to confirm in-
flammation and subclinical atherosclerosis in patients
with PD. However, further prospective studies are
needed to confirm a cause-and-effect relationship be-
tween NLR and baPWV and to investigate whether anti-
inflammatory treatment could improve arterial stiffness
in patients with PD.Additional file
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